









Markets
/
Stocks
/
nasdaq-bdrx
/

Biodexa Pharmaceuticals PLC

BDRX

View Detailed Chart

6.760USD

-0.220-3.15%

Close 08/06, 16:00（ET）Quotes delayed by 15 min

45.20BMarket Cap

--P/E TTM



Biodexa Pharmaceuticals PLC

6.760

-0.220-3.15%

Overview Company Financials

Financials

Intraday

30m

Today

-3.15%

5 Days

+682.68%

1 Month

+687.33%

6 Months

+62.11%

Year to Date

+66.91%

1 Year

-57.08%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts

STRONG BUY

Current Rating

180.000

Target Price

2478.80%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Biodexa Pharmaceuticals PLC

BDRX

CRISPR Therapeutics AG

CRSP

Ionis Pharmaceuticals Inc

IONS

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(2)

Neutral(2)

Buy(8)

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

1.406

Buy

RSI(14)

81.119

Overbought

STOCH(KDJ)(9,3,3)

75.000

Neutral

ATR(14)

0.859

High Vlolatility

CCI(14)

87.032

Neutral

Williams %R

25.101

Buy

TRIX(12,20)

14.005

Buy

StochRSI(14)

0.000

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

7.054

Sell

MA10

3.964

Buy

MA20

2.422

Buy

MA50

1.570

Buy

MA100

1.535

Buy

MA200

3.027

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Biodexa Pharmaceuticals PLC is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. The Q-Sphera technology focuses on long-acting injectables using proprietary three-dimensional (3D) printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. The MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. The MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility biological potential of Hydrogen (pH), extending available routes of administration, including direct-to-tumor delivery. Its pipeline includes MTX110, MTD201, MTD211 (Schizophrenia, MDD), MTX223, and MTD217.

Ticker SymbolBDRX

CompanyBiodexa Pharmaceuticals PLC

CEOMr. Stephen A. Stamp

Websitehttps://www.biodexapharma.com/